Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 282, Issue 5 51-5, 2002, Pages

  Raidel, Scott M ^a   Haase, Chad ^a   Jansen, Natalie R ^a   Russ, Rodney B ^a   Sutliff, Roy L ^a   Velsor, Leonard W ^b   Day, Brian J ^b   Hoit, Brian D ^c   Samare L, Allen M ^d   Lewis, William ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Acquired immunodeficiency syndrome; Cardiac dysfunction; echocardiogram; Oxidative stress; Transmission electron microscopy

Indexed keywords

ANTIOXIDANT; ATRIAL NATRIURETIC FACTOR; GLUTATHIONE; MESSENGER RNA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN ALPHA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GLUTATHIONE METABOLISM; HEART CONTRACTION; HEART DISEASE; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HOMOZYGOSITY; HUMAN IMMUNODEFICIENCY VIRUS; MITOCHONDRIAL MYOPATHY; MORTALITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSACTIVATION; TRANSGENIC MOUSE; WILD TYPE;

EID: 0036087347     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00955.2001     Document Type: Article

References (41)

1. Redox regulation of fos and jun DNA-binding activity in vitro
2. Angiogenic properties of human immunodeficiency virus type 1 Tat protein
3. Opportunistic invasion of the heart in Hispanic patients with acquired immunodeficiency syndrome
4. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients
5. Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy
6. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase
7. Altered cytokine expression in T lymphocytes from human immunodeficiency virus Tat transgenic mice
8. HIV type 1 extracellular Tat protein stimulates growth and protects cells of BK virus/tat transgenic mice from apoptosis
9. Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice
10. Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes
11. Mitochondrial myopathy caused by longterm zidovudine therapy
12. Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells
13. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes
14. Regulation of procollagen metabolism in the pressure-overloaded rat heart
15. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients
16. GSH transport in mitochondria: Defense against TNF-induced oxidative stress and alcohol-induced defect
17. HIV-1: Fifteen proteins and an RNA
18. Aberrant regulation of cytokines in HIV-1 TAT72-transgenic mice
19. Infection of the heart by the human immunodeficiency virus
20. Exogenous tat protein activates human endothelial cells
21. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency
22. Mechanisms of disease: Signaling pathways for cardiac hypertrophy and failure
23. Transgenic models of human immunodeficiency virus type-1
24. Transgenic models of HIV-1
25. Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma
26. Myocarditis diagnosed by endomyocardial biopsy in human immunodeficiency virus infection with cardiac dysfunction
27. Cardiomyopathy in AIDS: A pathophysiological perspective
28. Mitochondrial DNA depletion, oxidative stress and mutation: Mechanisms of nucleoside reverse transcriptase inhibitor toxicity
29. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria
30. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine
31. Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts
32. Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome
33. Transgenic remodeling of the contractile apparatus in the mammalian heart
34. Transgenic mouse model of ethanol as a cofactor in HIV disease
35. The human immunodeficiency virus type 1 Tat protein potentiates zidovudine-induced cellular toxicity in transgenic mice
36. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction
37. Remodeling the cardiac sarcomere using transgenesis
38. A low-viscosity epoxy resin embedding medium for electron microscopy
39. Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice
40. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice
41. Mitochondrial diseases in man and mouse